Biotech

Curis Provides Updated Data from its Frontline AML Triplet Study PR Newswire (Press Release)13:01
STAT Plus: Early update shows Wave’s RNA drug cut visceral fat STAT14:51
STAT Plus: Structure reports promising weight loss outcomes with obesity drug, but side effect… STAT14:16
STAT Plus: Kymera drug positioned to rival Sanofi and Regeneron’s Dupixent succeeds in… STAT12:04
Karyopharm to participate in Baird's biotech discovery series PR Newswire (Press Release)12:02
Sensorion reports independent Data Monitoring Committee raises no safety concerns and agrees to … Business Wire (Press Release)06:39
Indian tycoon Kiran Mazumdar-Shaw’s Biocon buyout deal values Biologics unit at $5.5 Billion Forbes07:40

Latest News

In the last 2 hours

Biotech Showcase™ 2026 Returns to San Francisco During JPM Week as a Premier Destination for… Business Wire (Press Release)15:04

Senti Announced Positive Phase 1 Data For Senti-202 In Relapsed/ Refractory AML RTT News14:54

STAT Plus: Terns leukemia drug could succeed Novartis blockbuster STAT14:41

In the last 4 hours

Lilly's Jaypirca Sees 80% Risk Of Disease Progression Or Death In Front-Line CLL/Sll Phase 3 Trial RTT News14:23

Teva Pharmaceuticals Submits NDA For Olanzapine Lai RTT News13:53

FUNAAB VC pushes for biotech tools to enhance agric. productivity News Diary Online13:52

Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy &… PR Newswire (Press Release)13:45

Bora Pharmaceuticals and Corealis Pharma Forge Strategic Alliance to Deliver Seamless,… PR Newswire (Press Release)13:41

Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor … PR Newswire (Press Release)13:41

Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer Business Wire (Press Release)13:34

Ose Immunotherapeutics Unveils 2026-2028 Strategic Plan With Four Value-Creating Opportunities RTT News13:22

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC… Business Wire (Press Release)13:14

Novastra Launches First-in-Human Trial of Next-Generation Immune Reprogramming Cancer Therapy for Hard-to-Treat Patients Newswise (Press Release)13:04

Ansa Biotechnologies Appoints Geoff Hamilton as Chief Financial Officer and Chief Business… Business Wire (Press Release)13:04

Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates Business Wire (Press Release)13:04

Delphia Therapeutics Appoints Leading Cancer Expert Steve Kelsey, M.D., to Board of Directors Business Wire (Press Release)13:04

Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links… Business Wire (Press Release)13:02

Curis Provides Updated Data from its Frontline AML Triplet Study PR Newswire (Press Release)13:01

Miami Biotech Collective Hosts Inaugural 2025 Annual Summit: The Art of Driving the Future of… PR Newswire (Press Release)13:01

Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer Business Wire (Press Release)12:51

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate … PR Newswire (Press Release)12:46

In the last 6 hours

Kelonia Therapeutics Presents First-in-Human Data From Phase 1 inMMyCAR Study of Kln-1010 in… Business Wire (Press Release)12:33

Icon 2025 global biotech survey solidifies China dominance and highlights opportunities for… Business Wire (Press Release)12:20

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific … BioNTech (Press Release)12:04

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief… Business Wire (Press Release)12:03

Biogen Receives Health Canada Authorization for Zurzuvae™ (zuranolone), the First and Only… Business Wire (Press Release)12:03

Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2… Business Wire (Press Release)12:03

ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development… Biotech, B3C newswire12:02

Dyne Delivers In Duchenne Trial; Now Aims To achieve Myotonic Dystrophy Milestones RTT News11:49

Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression… Business Wire (Press Release)11:31

Akeso Presents Positive Data Of Cadonilimab Regimen In Resectable Gastric Cancer At Esmo Asia 2025 RTT News11:30

Novartis Strikes Deal With UK Biotech for Up To $1.7 Billion (1) Bloomberg Law10:41

In the last 8 hours

Can America Win the New Race for Scientific Leadership? China US Focus10:29

How world-class infrastructure will reinforce Ghent’s position as Europe’s biopharma hub Labiotech09:09

BiomX Halts Phase 2b Trial Of BX004 In Cystic Fibrosis On High Rates Of Adverse Events RTT News09:07

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement … The Hindu Business Line09:03

Earlier today

Cardiff Presents Phase 1 Data Of Onvensertib In Chronic Myelomonocytic Leukemia At ash 2025 RTT News07:46

After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance RTT News05:21

Telangana’s loss is Andhra’s gain as pharma companies expand in Kurnool The Times of India05:15

4 ‘Buy’ recommendations by Nuvama, with up to 37% upside potential The Financial Express05:06

Fed Govt: biotechnology to drive development The Nation, Nigeria04:12

[Reporter's Notebook] Is Peptron’s trillion-won valuation built on solid ground or overstated expectations? Korea Biomedical Review02:32

Yesterday

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance… Biogen (Press Release)23:34 8-Dec-25

US Congress unveils bill with curbs on China tech investment and biotech ties South China Morning Post22:16 8-Dec-25

STAT Plus: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia STAT22:07 8-Dec-25

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Path To Profitability Simply Wall St22:04 8-Dec-25

Evaluating Insmed (INSM) After Its Strong 2024 Share Price Surge and Rare Disease Pipeline Progress Simply Wall St22:04 8-Dec-25

Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent… Business Wire (Press Release)21:36 8-Dec-25

Qihan Biotech Presents New Clinical Data on Allogeneic car-T Cell Therapies and Preclinical… Business Wire (Press Release)21:36 8-Dec-25

Late-Model Lab & Bioprocess Equipment From Premier Biopharma Facility To Be Offered For Sale… Pharmaceutical Online20:01 8-Dec-25

Cellarity Presents on Cell State-Correcting Pipeline Programs for Sickle Cell Disease and… Business Wire (Press Release)19:55 8-Dec-25

STAT Plus: Results in Terns leukemia drug study suggest it could be a successor to Novartis… STAT19:51 8-Dec-25

Slimmer price tag helps Wegovy sales gain weight The Times of India19:14 8-Dec-25

Respiratory drug sales peak in November amid worsening AQI The Times of India19:14 8-Dec-25

Flashpoint Therapeutics’ Scientific Founder Chad A. Mirkin Awarded the Prestigious Harvey Prize Business Wire (Press Release)18:11 8-Dec-25

Nigeria moves to update national biotechnology policy Peoples Gazette17:42 8-Dec-25

British Business Bank in record £75m fund commitment BusinessCloud.co.uk17:21 8-Dec-25

Genome Valley firm ATGC Biotech, Israel’s Luxembourg Industries set up JV The Hindu16:34 8-Dec-25

August 2026 Options Now Available For BioMarin Pharmaceutical (BMRN) Nasdaq16:28 8-Dec-25

Emirates Biotech launch its new PLA biopolymers line Interplas Insights16:19 8-Dec-25

In Gender Bias Appeal, 9th Circuit Eyes Viability of Compulsory Arbitration Under Statutes Law.com16:07 8-Dec-25

India’s biotechnology sector to reach $300 billion by 2030 The Statesman16:01 8-Dec-25

Department of Energy, PNNL Partner to Power the Nation’s Bioeconomy Newswise (Press Release)15:51 8-Dec-25

Kymera Announced Positive Phase 1b Data For Oral STAT6 Degrader KT-621 In Atopic Dermatitis RTT News15:31 8-Dec-25

Dermata Therapeutics To Launch First OTC Acne Kit In Mid-2026 RTT News15:21 8-Dec-25

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration &… PR Newswire (Press Release)15:01 8-Dec-25

STAT Plus: Early update shows Wave’s RNA drug cut visceral fat STAT14:51 8-Dec-25

STAT Plus: Structure reports promising weight loss outcomes with obesity drug, but side effect… STAT14:16 8-Dec-25

Top biotech deals in November 2025 Labiotech14:09 8-Dec-25

New Symptom-Management Guide Offers Practical Support for People Undergoing Metastatic Breast… PR Newswire (Press Release)14:03 8-Dec-25

The Galien Foundation Honors 2025 Prix Galien Bridges Awards Recipients PR Newswire (Press Release)14:03 8-Dec-25

GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody… PR Newswire (Press Release)13:39 8-Dec-25

OODA AI: Actionable Intelligence Powered by Advanced Retrieval-Augmented Generation PR Newswire (Press Release)13:38 8-Dec-25

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting PR Newswire (Press Release)13:33 8-Dec-25

A Bitcoin-Friendly President? Yes, A Crypto-Focused Strategy? Not Yet CoinEdition13:31 8-Dec-25

ASH: Gilead preps filing for anito-cel on iMMagine-1 data pharmaphorum13:23 8-Dec-25

ASH: Regeneron eyes simpler regimens in bid to move bispecifics into earlier blood cancer… FiercePharma13:18 8-Dec-25

Immix Soars On Nxc-201 Data In Relapsed/Refractory Al Amyloidosis; Bla Planned For 2026 RTT News13:15 8-Dec-25

Reid Waldman, M.D., Receives Entrepreneur of the Year Award for Visionary Work in Life Sciences Business Wire (Press Release)13:06 8-Dec-25

Orum Therapeutics Presents Preclinical Data at ash 2025 Demonstrating Potent and Selective… Business Wire (Press Release)13:06 8-Dec-25

Inductive Bio Announces an Up To $21M Award to Develop AI Drug Toxicity Models that Improve… PR Newswire (Press Release)13:03 8-Dec-25

Ascentage Presents Promising Registrational And Phase Ib/II Data Of Lisaftoclax At ash 2025 RTT News12:08 8-Dec-25

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer Business Wire (Press Release)12:05 8-Dec-25

STAT Plus: Kymera drug positioned to rival Sanofi and Regeneron’s Dupixent succeeds in… STAT12:04 8-Dec-25

ASH: Regeneron makes frontline case for Lynozyfic in myeloma pharmaphorum12:02 8-Dec-25

Karyopharm to Participate in Baird's Biotech Discovery Series PR Newswire (Press Release)12:02 8-Dec-25

BioNTech and OncoC4 Report Positive Phase 3 Trial Results for Gotistobart in Lung Cancer TipRanks11:54 8-Dec-25

STAT Plus: Dyne Therapeutics plans to file for approval for next-generation Duchenne drug STAT11:44 8-Dec-25

Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment… Business Wire (Press Release)11:35 8-Dec-25

Atgc Biotech forms joint venture with Israeli firm The Hindu Business Line11:06 8-Dec-25

Ibmi Snq and Ichom Forms Strategic Partnership in Asia, Advancing Patient-centered Healthcare… Business Wire (Press Release)11:04 8-Dec-25

Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas… PR Newswire (Press Release)11:01 8-Dec-25

China's lab fungus produces low-cost, meat-like protein to replace chicken farms South China Morning Post10:47 8-Dec-25

Biotech Melt&Marble raises €7.3m for sustainable fats product Silicon Republic10:14 8-Dec-25

Lyell's Ronde-cel Shows Durable Complete Responses With Manageable Safety In High-Risk Lbcl RTT News10:05 8-Dec-25

British Business Bank backs biotech fund with £75m commitment UKTN (UK Tech News)10:05 8-Dec-25

Viatris signs agreements with Biocon on $815m stake sale Pharmaceutical Business Review09:59 8-Dec-25

Agilent and Monash University Malaysia to set up biodiscovery hub Pharmaceutical Technology09:16 8-Dec-25

BioLumic Expands Light-Activated Seed Trait Platform To South America AgriMarketing09:01 8-Dec-25

Biocon shares decline despite analyst optimism on Biologics merger deal The Hindu Business Line08:47 8-Dec-25

Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug The Times of India08:02 8-Dec-25

India, Israel sign agreement to boost sustainable agricultural technologies AniNews.in07:55 8-Dec-25

Indian Tycoon Kiran Mazumdar-Shaw’s Biocon Buyout Deal Values Biologics Unit At $5.5 Billion Forbes07:40 8-Dec-25

Huons Group affiliates win Trade Day awards for developing global markets Korea JoongAng Daily07:37 8-Dec-25

Structure Therapeutics To Report Key Phase 2 Data For GLP-1 Agonist Aleniglipron In Obesity Today RTT News07:23 8-Dec-25

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.' PR Newswire (Press Release)06:42 8-Dec-25

Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to … Business Wire (Press Release)06:39 8-Dec-25

SK biopharmaceuticals aligns global strategy for epilepsy drug cenobamate at AES 2025 Korea Biomedical Review06:29 8-Dec-25

AsymBio Commences Commercial Operations at Fengxian Base, Strengthening Global… PR Newswire (Press Release)05:00 8-Dec-25

Healthcare Names Post Strong After-Hours Moves: Kymr, Ocul, Poai Among Top Gainers RTT News04:16 8-Dec-25

Biocon merger with Biocon Biologics: What does the $5.5 billion valuation mean for investors? The Financial Express03:38 8-Dec-25

Trump’s National Security Strategy Omits Crypto, Yet Hints at Bitcoin’s Role in US Finance Coinotag03:35 8-Dec-25

Huons Group garners multiple export honors at Trade Day ceremony Korea Biomedical Review02:24 8-Dec-25

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed… PR Newswire (Press Release)02:00 8-Dec-25

New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb)… JCN Newswire01:04 8-Dec-25

view more headlines

9 Dec 15:04

About our Biotech news

Latest Biotech news, covering the latest bioinformatics, bioengineering and more from the Biotechnology industry.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.